Schedule 13G ownership disclosure
Ligand Pharmaceuticals Inc
Security class unavailable · CUSIP: 53220K504
Event date: 2021-04-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-063074
- Form type
- SC 13G
- Filer
- LIGAND PHARMACEUTICALS INC
- CIK
- CIK 886163
- Filed
- May 07, 2021
- Reporting period
- Apr 30, 2021
- Description
- Schedule 13G beneficial ownership